Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy

NCT00611039 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Darunavir 900mg + ritonavir 100 mg once a day
DRUG: Darunavir 600mg + ritonavir 100mg twice day

Sponsor

Germans Trias i Pujol Hospital

Collaborators

[object Object]